Albuterol Inhaler Prescribing Guidelines

Introduction to Albuterol MDIs

The American Thoracic Society recommends metered-dose inhalers with spacers as the first-line non-powder inhaler option for most patients with asthma and COPD, providing effective bronchodilation with fewer side effects compared to nebulizers 1

The standard prescribed regimen for both asthma and COPD patients is albuterol 200-400 μg (2-4 puffs) up to four times daily, as recommended by the American College of Chest Physicians 1, 2

Nebulized albuterol solution is preferred in acute severe exacerbations requiring emergency department or hospital treatment, where nebulized albuterol 2.5-5 mg is administered every 4-6 hours, as recommended by the American Heart Association 3, 4, 2
Patients who cannot effectively use MDIs despite proper instruction and spacer devices should be prescribed nebulized albuterol, according to the American Thoracic Society 1
Patients requiring high-dose therapy (>1 mg albuterol per treatment) should be prescribed nebulized albuterol, as recommended by the American College of Chest Physicians 1

In COPD patients with CO2 retention and acidosis, nebulizers must always be driven by compressed air, NOT oxygen, to prevent worsening hypercapnia, as recommended by the American Thoracic Society 1, 5, 2

The American Heart Association does not recommend levalbuterol (the R-isomer of albuterol) over standard racemic albuterol, despite some studies showing slightly improved bronchodilation, due to lack of clear superiority 3, 4